These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15613147)

  • 1. The levels of chemokines CXCL8, CCL2 and CCL5 in multiple sclerosis patients are linked to the activity of the disease.
    Bartosik-Psujek H; Stelmasiak Z
    Eur J Neurol; 2005 Jan; 12(1):49-54. PubMed ID: 15613147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between IL-4, IL-12 levels and CCL2, CCL5 levels in serum and cerebrospinal fluid of multiple sclerosis patients.
    Bartosik-Psujek H; Stelmasiak Z
    J Neural Transm (Vienna); 2005 Jun; 112(6):797-803. PubMed ID: 15480850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid therapy altered serum levels of CCL2 and CCL5 chemokines in multiple sclerosis patients during relapse.
    Bartosik-Psujek H; Stelmasiak Z
    Eur Neurol; 2004; 52(4):237-41. PubMed ID: 15550762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes.
    Jalonen TO; Pulkkinen K; Ukkonen M; Saarela M; Elovaara I
    J Neurol; 2002 May; 249(5):576-83. PubMed ID: 12021948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis.
    Moreira MA; Tilbery CP; Monteiro LP; Teixeira MM; Teixeira AL
    Acta Neurol Scand; 2006 Aug; 114(2):109-13. PubMed ID: 16867033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine responses are increased in HIV-infected Malawian children with invasive pneumococcal disease.
    Carrol ED; Mankhambo LA; Balmer P; Nkhoma S; Banda DL; Guiver M; Jeffers G; Makwana N; Molyneux EM; Molyneux ME; Smyth RL; Hart CA;
    J Acquir Immune Defic Syndr; 2007 Apr; 44(4):443-50. PubMed ID: 17195767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial measurements of levels of the chemokines CCL2, CCL3 and CCL5 in serum of patients with acute ischaemic stroke.
    Zaremba J; Ilkowski J; Losy J
    Folia Neuropathol; 2006; 44(4):282-9. PubMed ID: 17183455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF-chemokines in HTLV-I-associated myelopathy: CXCL10 up-regulation and therapeutic effect of interferon-alpha.
    Narikawa K; Fujihara K; Misu T; Feng J; Fujimori J; Nakashima I; Miyazawa I; Saito H; Sato S; Itoyama Y
    J Neuroimmunol; 2005 Feb; 159(1-2):177-82. PubMed ID: 15652417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis.
    Narikawa K; Misu T; Fujihara K; Nakashima I; Sato S; Itoyama Y
    J Neuroimmunol; 2004 Apr; 149(1-2):182-6. PubMed ID: 15020078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of serum levels of chemokines during interferon-β treatment in multiple sclerosis patients: a 1-year, observational cohort study.
    Comini-Frota ER; Teixeira AL; Angelo JP; Andrade MV; Brum DG; Kaimen-Maciel DR; Foss NT; Donadi EA
    CNS Drugs; 2011 Nov; 25(11):971-81. PubMed ID: 22054120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of TH1/TH2-related chemokine receptors on peripheral T cells and correlation with clinical disease activity in patients with multiple sclerosis.
    Nakajima H; Fukuda K; Doi Y; Sugino M; Kimura F; Hanafusa T; Ikemoto T; Shimizu A
    Eur Neurol; 2004; 52(3):162-8. PubMed ID: 15528917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CC chemokines CCL2, CCL5, and CCL11 is associated with duration of disease and complications in type-1 diabetes: a study on Iranian diabetic patients.
    Jamali Z; Nazari M; Khoramdelazad H; Hakimizadeh E; Mahmoodi M; Karimabad MN; Hassanshahi G; Rezaeian M; Balaei P; Darakhshan S; Poor NM
    Clin Lab; 2013; 59(9-10):993-1001. PubMed ID: 24273921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of CCL2 and CXCL8 chemokines in serum, bronchoalveolar lavage fluid and lung tissue samples from dogs affected with canine idiopathic pulmonary fibrosis.
    Roels E; Krafft E; Farnir F; Holopainen S; Laurila HP; Rajamäki MM; Day MJ; Antoine N; Pirottin D; Clercx C
    Vet J; 2015 Oct; 206(1):75-82. PubMed ID: 26231926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokines in the cerebrospinal fluid of patients with active and stable relapsing-remitting multiple sclerosis.
    Moreira MA; Souza AL; Lana-Peixoto MA; Teixeira MM; Teixeira AL
    Braz J Med Biol Res; 2006 Apr; 39(4):441-5. PubMed ID: 16612466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential release of beta-chemokines in serum and CSF of patients with relapsing-remitting multiple sclerosis.
    Sindern E; Niederkinkhaus Y; Henschel M; Ossege LM; Patzold T; Malin JP
    Acta Neurol Scand; 2001 Aug; 104(2):88-91. PubMed ID: 11493224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum levels of CXCL9/monokine induced by interferon-gamma and CXCL10/interferon-gamma-inducible protein-10 in ocular sarcoidosis.
    Takeuchi M; Oh-I K; Suzuki J; Hattori T; Takeuchi A; Okunuki Y; Usui Y; Usui M
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1063-8. PubMed ID: 16505042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis.
    Sørensen TL; Sellebjerg F; Jensen CV; Strieter RM; Ransohoff RM
    Eur J Neurol; 2001 Nov; 8(6):665-72. PubMed ID: 11784351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCL5, CXCL10 and CXCL11 chemokines in patients with active and stable relapsing-remitting multiple sclerosis.
    Szczuciński A; Losy J
    Neuroimmunomodulation; 2011; 18(1):67-72. PubMed ID: 20720435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of chemokines in the CSF and correlation with clinical disease activity in patients with multiple sclerosis.
    Mahad DJ; Howell SJ; Woodroofe MN
    J Neurol Neurosurg Psychiatry; 2002 Apr; 72(4):498-502. PubMed ID: 11909910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine CCL2 and chemokine receptor CCR2 in early active multiple sclerosis.
    Sørensen TL; Ransohoff RM; Strieter RM; Sellebjerg F
    Eur J Neurol; 2004 Jul; 11(7):445-9. PubMed ID: 15257681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.